These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Deficiency of the Hck and Src tyrosine kinases results in extreme levels of extramedullary hematopoiesis. Lowell CA; Niwa M; Soriano P; Varmus HE Blood; 1996 Mar; 87(5):1780-92. PubMed ID: 8634424 [TBL] [Abstract][Full Text] [Related]
8. Expression, purification, and biochemical characterization of Chk, a soluble protein tyrosine kinase. Ayrapetov MK; Lee S; Sun G Protein Expr Purif; 2003 Jun; 29(2):148-55. PubMed ID: 12767803 [TBL] [Abstract][Full Text] [Related]
9. Chk, a Csk family tyrosine protein kinase, exhibits Csk-like activity in fibroblasts, but not in an antigen-specific T-cell line. Davidson D; Chow LM; Veillette A J Biol Chem; 1997 Jan; 272(2):1355-62. PubMed ID: 8995444 [TBL] [Abstract][Full Text] [Related]
10. Interplay between the tyrosine kinases Chk and Csk and phosphatase PTPRJ is critical for regulating platelets in mice. Nagy Z; Mori J; Ivanova VS; Mazharian A; Senis YA Blood; 2020 Apr; 135(18):1574-1587. PubMed ID: 32016283 [TBL] [Abstract][Full Text] [Related]
11. Differential expression of Csk homologous kinase (CHK) in normal brain and brain tumors. Kim SO; Avraham S; Jiang S; Zagozdzon R; Fu Y; Avraham HK Cancer; 2004 Sep; 101(5):1018-27. PubMed ID: 15329911 [TBL] [Abstract][Full Text] [Related]
12. Csk-homologous kinase (Chk) is an efficient inhibitor of Src-family kinases but a poor catalyst of phosphorylation of their C-terminal regulatory tyrosine. Advani G; Lim YC; Catimel B; Lio DSS; Ng NLY; Chüeh AC; Tran M; Anasir MI; Verkade H; Zhu HJ; Turk BE; Smithgall TE; Ang CS; Griffin M; Cheng HC Cell Commun Signal; 2017 Aug; 15(1):29. PubMed ID: 28784162 [TBL] [Abstract][Full Text] [Related]
13. A novel non-catalytic mechanism employed by the C-terminal Src-homologous kinase to inhibit Src-family kinase activity. Chong YP; Mulhern TD; Zhu HJ; Fujita DJ; Bjorge JD; Tantiongco JP; Sotirellis N; Lio DS; Scholz G; Cheng HC J Biol Chem; 2004 May; 279(20):20752-66. PubMed ID: 14985335 [TBL] [Abstract][Full Text] [Related]
14. Identification of the nonreceptor tyrosine kinase MATK/CHK as an essential regulator of immune cells using Matk/CHK-deficient mice. Lee BC; Avraham S; Imamoto A; Avraham HK Blood; 2006 Aug; 108(3):904-7. PubMed ID: 16574955 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of C-terminal Src kinase homologous kinase suppresses activation of Lyn tyrosine kinase required for VLA5-mediated Dami cell spreading. Hirao A; Huang XL; Suda T; Yamaguchi N J Biol Chem; 1998 Apr; 273(16):10004-10. PubMed ID: 9545346 [TBL] [Abstract][Full Text] [Related]
16. Csk homologous kinase, a novel signaling molecule, directly associates with the activated ErbB-2 receptor in breast cancer cells and inhibits their proliferation. Zrihan-Licht S; Deng B; Yarden Y; McShan G; Keydar I; Avraham H J Biol Chem; 1998 Feb; 273(7):4065-72. PubMed ID: 9461599 [TBL] [Abstract][Full Text] [Related]
17. Csk homologous kinase (CHK), unlike Csk, enhances MAPK activation via Ras-mediated signaling in a Src-independent manner. Zagozdzon R; Kaminski R; Fu Y; Fu W; Bougeret C; Avraham HK Cell Signal; 2006 Jun; 18(6):871-81. PubMed ID: 16168623 [TBL] [Abstract][Full Text] [Related]
18. Conserved hydrophobicity in the SH2-kinase linker is required for catalytic activity of Csk and CHK. Mikkola ET; Bergman M FEBS Lett; 2003 Jun; 544(1-3):11-4. PubMed ID: 12782282 [TBL] [Abstract][Full Text] [Related]
19. C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)--endogenous negative regulators of Src-family protein kinases. Chong YP; Mulhern TD; Cheng HC Growth Factors; 2005 Sep; 23(3):233-44. PubMed ID: 16243715 [TBL] [Abstract][Full Text] [Related]
20. The Csk homologous kinase, Chk, binds tyrosine phosphorylated paxillin in human blastic T cells. Grgurevich S; Mikhael A; McVicar DW Biochem Biophys Res Commun; 1999 Mar; 256(3):668-75. PubMed ID: 10080957 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]